There was no clinical death, hemolysis, infection, or embolism during patients’ hospitalization and the follow-up period.Conclusion: Stand-alone transthoracic echocardiography-guided percutaneous PDA occlusion without the use of X-ray equipment is a safe and effective procedure.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: We aimed to investigate the feasibility and safety of stand-alone transthoracic echocardiography-guided percutaneous occlusion of patentductus arteriosus (PDA) without the use of X-ray equipment.Methods: From January to December 2015, we performed stand-alone transthoracic echocardiography-guided percutaneous PDA occlusion usingan occluder delivered via a delivery sheath introduced via femoral vein access without the use of X-ray equipment in 12 PDA patients.Results: PDA occlusion was successfully performed in all 12 patients.
📊
Key Findings & Data:The procedure duration ranged from 30 to 110 min (50.4±22.8 min), and the sizeof the implanted occluder ranged from 12 to 20 mm (15.2±2.8 mm).
💡
Conclusion & Impact:There was no clinical death, hemolysis, infection, or embolism during patients’ hospitalization and the follow-up period.Conclusion: Stand-alone transthoracic echocardiography-guided percutaneous PDA occlusion without the use of X-ray equipment is a safe and effective procedure.
🔬Design:Research Article
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters
Özet
Objective: We aimed to investigate the feasibility and safety of stand-alone transthoracic echocardiography-guided percutaneous occlusion of patentductus arteriosus (PDA) without the use of X-ray equipment.Methods: From January to December 2015, we performed stand-alone transthoracic echocardiography-guided percutaneous PDA occlusion usingan occluder delivered via a delivery sheath introduced via femoral vein access without the use of X-ray equipment in 12 PDA patients.Results: PDA occlusion was successfully performed in all 12 patients. The procedure duration ranged from 30 to 110 min (50.4±22.8 min), and the sizeof the implanted occluder ranged from 12 to 20 mm (15.2±2.8 mm). No occluder migration, residual shunt, or thrombotic complications were observedin the perioperative period. There was no clinical death, hemolysis, infection, or embolism during patients’ hospitalization and the follow-up period.Conclusion: Stand-alone transthoracic echocardiography-guided percutaneous PDA occlusion without the use of X-ray equipment is a safe and effective procedure.
🔖
Cite This Article
CAO, H., CHEN, Q., ZHANG, G., CHEN, L., XU, F., ZHANG, J. (2018). Clinical study of stand-alone transthoracic echocardiography-guided percutaneous occlusion of patent ductus arteriosus. The Anatolian Journal of Cardiology, Cilt: 20 - Sayı: 1, 30–34. https://ajindex.com/articles/367225
Schneider M, Hildebrandt N, Schweigl T, Wehner M. Transthoracic echocardiographic measurement of patent ductus arteriosus in dogs. J Vet Intern Med 2007; 21: 251-7. [CrossRef] Kudo Y, Suda K, Yoshimoto H, Teramachi Y, Kishimoto S, Iemura M, et al. Trans-pulmonary echocardiography as a guide for device closure of patent ductus arteriosus. Catheter Cardiovasc Interv 2015; 86: 264-70. [CrossRef] Liang CD, Ko SF, Huang SC. Echocardiographic guidance for transcatheter coil occlusion of patent ductus arteriosus in the catheterization laboratory. J Am Soc Echocardiogr 2003; 16: 476-9. [CrossRef] Chugh R, Salem MM. Echocardiography for patent ductus arteriosus including closure in adults. Echocardiography 2015; 32(Suppl 2): S125-39. [CrossRef] Tanıdır IC, Güzeltaş A, Ergül Y, Oztürk E, Ozyılmaz I, Odemiş E. Transcatheter patent ductus arteriosus closure with echocardiographic guidance: can radiation exposure be reduced? Turk Kardiyol Dern Ars 2014; 42: 643-50. [CrossRef] Chen W, Yan X, Huang Y, Sun X, Zhong L, Li J, et al. Transthoracic echocardiography as an alternative major guidance to angiography during transcatheterclosure of patent ductus arteriosus: technical feasibility and clinical relevance. Pediatr Cardiol 2015; 36: 14-9. [CrossRef] Khan MA, ElSegaier M, Galal MO. Percutaneous Closure of Patent Ductus Arteriosus Under Echocardiographic Guidance. J Coll Physicians Surg Pak 2016; 26: 533-5.
Garg G, Srivastava A, Tyagi H, Reddy SP, Radha AS. Transcatheter device closure of patent ductus arteriosus without arterial access- -single institution experience. Indian Heart J 2013; 65: 546-51. [CrossRef] Baykan A, Narin N, Özyurt A, Argun M, Pamukçu Ö, Onan SH, et al. Do we need a femoral artery route for transvenous PDA closure in children with ADO-I? Anatol J Cardiol 2015; 15: 242-7. [CrossRef] Thanopoulos BV, Ninios V, Dardas P, Giannopoulos A, Deleanou D, Iancovici S. Catheter Closure Through a Venous Approach of Patent Ductus Arteriosus in Small Pediatric Patients Using Combined Angiographic and Echocardiographic Guidance. Am J Cardiol 2016; 118: 1558-62. [CrossRef] Lam JY, Lopushinsky SR, Ma IW, Dicke F, Brindle ME. Treatment Options for Pediatric Patent Ductus Arteriosus: Systematic Review and Meta-analysis. Chest 2015; 148: 784-93. [CrossRef] Hongxin L, Wenbin G, Zhu M, Liang F, Zhang W, Mujahid H, et al. New minimally invasive technique of perpulmonary device closure of patent ductus arteriosus through a parasternal approach. Ann Thorac Surg 2012; 93: 862